SCIANDA Trademark

Trademark Overview

On Tuesday, August 20, 2013, a trademark application was filed for SCIANDA with the United States Patent and Trademark Office. The USPTO has given the SCIANDA trademark a serial number of 86042807. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, November 22, 2023. This trademark is owned by ScinoPharm Taiwan, Ltd.. The SCIANDA trademark is filed in the Pharmaceutical Products category with the following description:

Active pharmaceutical ingredients sold as integral components of pharmaceutical preparations for treating cancer, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, respiratory diseases, mental diseases, ophthalmic diseases, digestive diseases, endocrine diseases, diseases of muscle-skeletal system, metabolic disorder diseases, diseases of central nervous system, cardiovascular diseases; medicines for use in humans for treating cancer, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, respiratory diseases, mental diseases, ophthalmic diseases, digestive diseases, endocrine diseases, diseases of muscle-skeletal system, metabolic disorder diseases, diseases of central nervous system, cardiovascular diseases
scianda

General Information

Serial Number86042807
Word MarkSCIANDA
Filing DateTuesday, August 20, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, November 22, 2023
Registration Number5211478
Registration DateTuesday, May 30, 2017
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 14, 2017

Trademark Statements

Description of MarkThe mark consists of the invented wording "SciAnda".
Goods and ServicesActive pharmaceutical ingredients sold as integral components of pharmaceutical preparations for treating cancer, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, respiratory diseases, mental diseases, ophthalmic diseases, digestive diseases, endocrine diseases, diseases of muscle-skeletal system, metabolic disorder diseases, diseases of central nervous system, cardiovascular diseases; medicines for use in humans for treating cancer, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, respiratory diseases, mental diseases, ophthalmic diseases, digestive diseases, endocrine diseases, diseases of muscle-skeletal system, metabolic disorder diseases, diseases of central nervous system, cardiovascular diseases
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 28, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameScinoPharm Taiwan, Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressShan-Hua, Tainan 74144
TW
Party NameScinoPharm Taiwan, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressShan-Hua, Tainan 74144
TW
Party NameScinoPharm Taiwan, Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressShan-Hua, Tainan 74144
TW

Trademark Events

Event DateEvent Description
Wednesday, November 22, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, November 22, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, November 22, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, May 25, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, May 30, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 30, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, March 14, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2017PUBLISHED FOR OPPOSITION
Wednesday, February 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 3, 2017NOTICE OF ALLOWANCE CANCELLED
Friday, February 3, 2017ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Friday, February 3, 2017PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Friday, January 27, 2017ASSIGNED TO PETITION STAFF
Friday, December 16, 2016TEAS PETITION TO AMEND BASIS RECEIVED
Friday, December 9, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 8, 2016SOU EXTENSION 5 GRANTED
Monday, November 21, 2016SOU EXTENSION 5 FILED
Monday, November 21, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, June 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 14, 2016SOU EXTENSION 4 GRANTED
Tuesday, May 31, 2016SOU EXTENSION 4 FILED
Tuesday, May 31, 2016SOU TEAS EXTENSION RECEIVED
Thursday, December 3, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 2, 2015SOU EXTENSION 3 GRANTED
Tuesday, November 24, 2015SOU EXTENSION 3 FILED
Tuesday, November 24, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, May 19, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 18, 2015SOU EXTENSION 2 GRANTED
Tuesday, April 14, 2015SOU EXTENSION 2 FILED
Friday, May 15, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 14, 2015SOU TEAS EXTENSION RECEIVED
Thursday, December 4, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 2, 2014SOU EXTENSION 1 GRANTED
Tuesday, December 2, 2014SOU EXTENSION 1 FILED
Tuesday, December 2, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, June 17, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 22, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 22, 2014PUBLISHED FOR OPPOSITION
Wednesday, April 2, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 15, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 12, 2014ASSIGNED TO LIE
Monday, February 24, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 21, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 20, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 20, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 5, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 5, 2013NON-FINAL ACTION E-MAILED
Thursday, December 5, 2013NON-FINAL ACTION WRITTEN
Thursday, December 5, 2013ASSIGNED TO EXAMINER
Wednesday, August 28, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 23, 2013NEW APPLICATION ENTERED

Related Keywords

scianda diseases system endocrine cardiovascular digestive ophthalmic muscle skeletal central disorder